Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1952 2
1953 1
1992 3
1996 2
2001 2
2002 1
2003 1
2004 4
2005 8
2006 13
2007 6
2008 5
2009 5
2010 3
2011 5
2012 8
2013 3
2014 1
2015 3
2016 5
2017 8
2018 7
2019 6
2020 7
2021 5
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. Male C, et al. Among authors: thelen k. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5. Lancet Haematol. 2020. PMID: 31699660 Free article. Clinical Trial.
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation.
Young G, Lensing AWA, Monagle P, Male C, Thelen K, Willmann S, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bajolle F, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Beyer-Westendorf J, Martinelli I, Massicotte MP, Smith WT, Berkowitz SD, Schmidt S, Price V, Prins MH, Kubitza D; EINSTEIN-Jr. Phase 3 Investigators. Young G, et al. Among authors: thelen k. J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4. J Thromb Haemost. 2020. PMID: 32246743 Free article. Clinical Trial.
Carbon-Negative Biofuel Production.
Kim S, Zhang X, Reddy AD, Dale BE, Thelen KD, Jones CD, Izaurralde RC, Runge T, Maravelias C. Kim S, et al. Among authors: thelen kd. Environ Sci Technol. 2020 Sep 1;54(17):10797-10807. doi: 10.1021/acs.est.0c01097. Epub 2020 Aug 19. Environ Sci Technol. 2020. PMID: 32786588
The cholangiocyte primary cilium in health and disease.
Mansini AP, Peixoto E, Thelen KM, Gaspari C, Jin S, Gradilone SA. Mansini AP, et al. Among authors: thelen km. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1245-1253. doi: 10.1016/j.bbadis.2017.06.006. Epub 2017 Jun 15. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28625917 Free PMC article. Review.
HERV-K: the biologically most active human endogenous retrovirus family.
Tönjes RR, Löwer R, Boller K, Denner J, Hasenmaier B, Kirsch H, König H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J, Thelen K, Löwer J, Kurth R. Tönjes RR, et al. Among authors: thelen k. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S261-7. doi: 10.1097/00042560-199600001-00039. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8797733 Review.
An update on computational oral absorption simulation.
Dressman JB, Thelen K, Willmann S. Dressman JB, et al. Among authors: thelen k. Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1345-64. doi: 10.1517/17425255.2011.617743. Epub 2011 Sep 23. Expert Opin Drug Metab Toxicol. 2011. PMID: 21939427 Review.
113 results